Congo Ebola Outbreak Claims 65 Lives as Virus Spreads Across Borders
Kinshasa, 15 May 2026
A deadly Ebola outbreak in eastern Democratic Republic of Congo has killed 65 people with 246 suspected cases reported in Ituri province. The outbreak involves the rare Bundibugyo strain, for which no licensed vaccine exists, making containment more challenging than previous outbreaks.
Outbreak Confirmation and Geographic Spread
The Africa Centres for Disease Control and Prevention officially declared the outbreak on 15 May 2026, confirming 65 deaths and 246 suspected cases concentrated primarily in the Mongwalu and Rwampara health zones of Ituri province [1][2]. Preliminary laboratory tests conducted by the Institut National de Recherche Biomédicale in Kinshasa detected the Ebola virus in 13 of 20 samples analysed [1]. The outbreak has already crossed international borders, with Uganda’s health ministry confirming one imported case on 16 May 2026 - a 59-year-old Congolese man who died in a Kampala hospital on 13 May after travelling from the DRC [1]. This cross-border transmission has heightened regional concerns, particularly given that Ituri province shares borders with both Uganda and South Sudan [2].
Dangerous Bundibugyo Strain Complicates Response
What makes this outbreak particularly concerning is the identification of the Bundibugyo strain of Ebola, rather than the more common Zaire strain [2]. Unlike the Zaire strain, for which vaccines are available, there is currently no licensed vaccine for the Bundibugyo strain [2]. This represents a significant challenge for containment efforts, as previous outbreaks of this particular strain occurred only twice before - in 2007 and 2012 [2]. The Democratic Republic of Congo has experienced 16 previous Ebola outbreaks since the virus was first identified there in 1976, but most involved the Zaire strain [2]. Health experts have expressed alarm at the scale of casualties before the outbreak was formally announced, with Dr Jennifer Nuzzo from Brown University’s Pandemic Center noting it was ‘pretty stunning to have first notice of an outbreak in D.R.C., which is very experienced, and have it be so large’ [3].
Regional Response and Cross-Border Coordination
Africa CDC convened an urgent meeting on Friday, 15 May 2026, with authorities from the Democratic Republic of Congo, Uganda, and South Sudan, alongside the World Health Organization and pharmaceutical companies including Merck & Co., Johnson & Johnson, and Moderna [2]. Dr Jean Kaseya, Africa CDC’s executive director, emphasised that ‘significant population movement between affected areas and neighbouring countries meant regional coordination was essential’ [1]. The meeting aimed to establish response protocols and enhance cross-border surveillance mechanisms to prevent further international spread [1]. Uganda has implemented heightened surveillance measures, though no local cases have been identified within its borders as of 14 May 2026 [1].
Historical Context and Ongoing Challenges
This latest outbreak occurs in a region already devastated by previous Ebola episodes. Between 2018 and 2020, eastern Congo experienced its deadliest Ebola outbreak, resulting in nearly 2,300 deaths from an estimated total that affected the broader region [1][2]. More recently, in 2025, an outbreak in Bulape, Kasai province, led to 45 deaths [1]. The current outbreak in Ituri province presents additional complexities due to the area’s designation under military rule since 2021 [1]. Dr Michael Head from the University of Southampton identified multiple contributing factors, including ‘close human contact with animal reservoirs, most likely bats but possibly also primates’, along with population movement between rural and urban areas, tropical climate conditions, and extensive rainforest coverage [2]. The mining activities in Ituri province, where people are constantly coming and going, make infectious disease control particularly challenging [2].